Abstract
Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) is demonstrated to be a potentially useful tool for the rapid identification of yeasts, the grouping of Candida albicans strains, and the monitoring of germ tube-specific markers. Co-crystallized with sinapinic acid as the MALDI matrix, intact yeast cells yielded a sufficient number of medium-sized ions (4–15 kDa) in MALDI mass spectra to provide “mass signatures” that were diagnostic of strain type. For most isolates, the mass signatures were affected by the growth medium, length of incubation and the cell preparation method. While the overall past success of this methodology for fungal cells has been relatively low compared to its application to bacteria, fixing the yeast cells in 50% methanol inactivated the cells, reduced cell aggregation in aqueous suspension solution, and more importantly, it significantly improved the mass signature quality. This simple but critical advance in sample treatment improved mass spectrometric signal-to-noise ratios and allowed the identification of yeasts by a mass signature approach. Under optimized conditions, Candida species (C. albicans, C. glabrata, C. krusei, C. kefyr), Aspergillus species (A. terreus, A. fumigatus, A. syndowii) and other yeast genera (Cryptococcus neoformans, Saccharomyces cerevisiae and a Rhodotorula sp.) could be distinguished. Within the C. albicans species, several common ions in the m/z 5,000–10,000 range were apparent in the mass spectra of all tested strains. In addition to shared ions, the mass spectra of individual C. albicans strains permitted grouping of the strains. Principal component analysis (PCA) was employed to confirm spectral reproducibility and C. albicans strain grouping by mass signatures. Finally, C. albicans germ tubes produced MALDI-TOF mass signatures that differed from yeast forms of this species. This is a rapid, sensitive and simple method for identifying yeasts, grouping strains and following the morphogenesis of C. albicans.
Similar content being viewed by others
References
Enache-Angoulvant A, Hennequin C (2005) Clin Infect Dis 41:1559–1568
Hazen KC (1995) Clin Microbiol Rev 8:462–478
Perfect JR, Casadevall A (2002) Infect Dis Clin North Am 16:837–874
Ruhnke M (2006) Curr Drug Targets 7:495–504
Pincus DH, Orenga S, Chatellier S (2007) Medical Mycol 45:97–121
Shepard JR, Addison RM, Alexander BD, Della-Latta P, Gherna M, Haase G, Hall G, Johnson JK, Merz WG, Peltroche-Llacsahuanga H, Stender H, Venezia RA, Wilson D, Procop GW, Wu F, Fiandaca MJ (2007) J Clin Microbiol (in press)
Timmins EM, Howell SA, Alsberg BK, Noble WC, Goodacre R (1998) J Clin Microbiol 36:367–374
Himmelreich U, Somorjai RL, Dolenko B, Lee OC, Daniel HM, Murray R, Mountford CE, Sorrell TC (2003) Appl Environ Microbiol 69:4566–4574
Himmelreich U, Somorjai RL, Dolenko B, Daniel HM, Sorrell TC (2005) FEMS Microbiol Lett 251:327–332
Ibelings MS, Maquelin K, Endtz HP, Bruining HA, Puppels GJ (2005) Clin Microbiol Infect 11:353–358
Maquelin K, Choo-Smith LP, Endtz HP, Bruining HA, Puppels GJ (2002) J Clin Microbiol 40:594–600
Tintelnot K, Haase G, Seibold M, Bergmann F, Staemmler M, Franz T, Naumann D (2000) J Clin Microbiol 38:1599–1608
Maquelin K, Choo-Smith LP, van Vreeswijk T, Endtz HP, Smith B, Bennett R, Bruining HA, Puppels GJ (2000) Anal Chem 72:12–19
Fenselau C, Demirev PA (2001) Mass Spectrom Rev 20:157–171
Gantt SL, Valentine NB, Saenz AJ, Kingsley MT, Wahl KL (1999) J Am Soc Mass Spectrom 10:1131–1137
Holland RD, Wilkes JG, Rafii F, Sutherland JB, Persons CC, Voorhees KJ, Lay JO (1996) Rapid Commun Mass Spectrom 10:1227–1232
Krishnamurthy T, Ross PL, Rajamani U (1996) Rapid Commun Mass Spectrom 10:883–888
Evason DJ, Claydon MA, Gordon DB (2001) J Am Soc Mass Spectrom 12:49–54
Haag AM, Taylor SN, Johnston KH, Cole RB (1998) J Mass Spectrom 33:750–756
Hathout Y, Demirev PA, Ho YP, Bundy JL, Ryzhov V, Sapp L, Stutler J, Jackman J, Fenselau C (1999) Appl Environ Microbiol 65:4313–4319
Horneffer V, Haverkamp J, Janssen HG, Notz R (2004) J Am Soc Mass Spectrom 15:1444–1454
Lay JO, Holland RD (2000) Methods Mol Biol 146:461–487
Madonna AJ, Basile F, Furlong E, Voorhees KJ (2001) Rapid Commun Mass Spectrom 15:1068–1074
Marvin-Guy LF, Parche S, Wagniere S, Moulin J, Zink R, Kussmann M, Fay LB (2004) J Am Soc Mass Spectrom 15:1222–1227
Ryzhov V, Hathout Y, Fenselau C (2000) Appl Environ Microbiol 66:3828–3834
Shaw EI, Moura H, Woolfitt AR, Ospina M, Thompson HA, Barr JR (2004) Anal Chem 76:4017–4022
Vargha M, Takáts Z, Konopka A, Nakatsu CH (2006) J Microbiol Methods 66:399–409
Williams TL, Andrzejewski D, Lay JO, Musser SM (2003) J Am Soc Mass Spectrom 14:342–351
Wunschel SC, Jarman KH, Petersen CE, Valentine NB, Wahl KL, Schauki D, Jackman J, Nelson CP, White E (2005) J Am Soc Mass Spectrom 16:456–462
Maier T, Klepel S, Renner U, Kostrzewa M (2006) Nat Method 3. doi:10.1038/nmeth1870
Amiri-Eliasi BJ, Fenselau C (2001) Anal Chem 73:5228–5231
Chen HY, Chen YC (2005) Rapid Commun Mass Spectrom 19:3564–3568
Jackson KA, Edwards-Jones V, Sutton CW, Fox AJ (2005) J Microbiol Methods 62:273–284
Li TY, Liu BH, Chen YC (2000) Rapid Commun Mass Spectrom 14:2393–2400
Valentine NB, Wahl JH, Kingsley MT, Wahl KL (2002) Rapid Commun Mass Spectrom 16:1352–1357
Whelan WL, Delga JM, Wadsworth E, Walsh TJ, Kwonchung KJ, Calderone R, Lipke PN (1990) Infect Immun 58:1552–1557
Han YM, Cutler JE (1995) Infect Immun 63:2714–2719
Qian QF, Jutila MA, Van Rooijen N, Cutler JE (1994) J Immunol 152:5000–5008
Benson ES, Filler SC, Berman J (2002) Eukaryot Cell 1:787–798
Palmer GE, Kelly MN, Sturtevant JE (2005) Eukaryot Cell 4:1677–1686
Xiang F, Beavis RC (1994) Rapid Commun Mass Spectrom 8:199–204
Vorm O, Roepstorff P, Mann M (1994) Anal Chem 66:3281–3287
Karas M, Hillenkamp F (1988) Anal Chem 60:2299–2301
Harrington PD, Street TE, Voorhees KJ, Dibrozolo FR, Odom RW (1989) Anal Chem 61:715–719
Harrington PD, Voorhees KJ (1990) Anal Chem 62:729–734
Sherburn RE, Jenkins RO (2003) Spectroscopy 17:31–38
Arnold RJ, Reilly JP (1998) Rapid Commun Mass Spectrom 12:630–636
Saenz AJ, Petersen CE, Valentine NB, Gantt SL, Jarman KH, Kingsley MT, Wahl KL (1999) Rapid Commun Mass Spectrom 13:1580–1585
Chaffin WL, Lopez-Ribot JL, Casanova M, Gozalbo D, Martinez JP (1998) Microbiol Mol Biol Rev 62:130–180
Farmer TB, Caprioli RM (1998) J Mass Spectrom 33:697–704
Woods AS, Buchsbaum JC, Worrall TA, Berg JM, Cotter RJ (1995) Anal Chem 67:4462–4465
Strupat K, Sagi D, Bonisch H, Schafer G, Peter-Katalinic J (2000) Analyst 125:653–657
Cai Y, Jiang YJ, Cole RB (2003) Anal Chem 75:1638–1644
Beavis RC, Chait BT (1989) Rapid Commun Mass Spectrom 3:432–435
Beavis RC, Chait BT (1990) Proc Natl Acad Sci USA 87:6873–6877
Gluckmann M, Pfenninger A, Kruger R, Thierolf M, Karas M, Horneffer V, Hillenkamp F, Strupat K (2001) Int J Mass Spectrom 210:121–132
Acknowledgement
The authors would like to thank Patrick Lambert and Dr. Miriam Corti for their help in yeast sample preparations. Support for the research was provided by the Research Institute for Children, Children’s Hospital, New Orleans, and the Louisiana Board of Regents through HEF (2001-06)-08.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Qian, J., Cutler, J.E., Cole, R.B. et al. MALDI-TOF mass signatures for differentiation of yeast species, strain grouping and monitoring of morphogenesis markers. Anal Bioanal Chem 392, 439–449 (2008). https://doi.org/10.1007/s00216-008-2288-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-008-2288-1